Evidence map›Paper›PMID 42568189›Full record

ArticleBioinformatics (Oxford, England)2026

MOZAIC: compound growth via in silico reactions and global optimization using Conformational Space Annealing.

Jinhyeok Yoo, Woong-Hee Shin

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jinhyeok YooDepartment of Biomedical Informatics, Korea University College of Medicine, Seoul 02708, Republic of Korea.
Woong-Hee ShinDepartment of Biomedical Informatics, Korea University College of Medicine, Seoul 02708, Republic of Korea.ORCID 0000-0003-3462-0243

Funding

Korea government (Ministry of Science and ICT) RS-2024-00441029Korea University K2327351National Research Foundation (NRF)
6 · The paper itself

Abstract

motivationFragment-based drug discovery (FBDD) efficiently explores chemical space by combining small molecular fragments. Advances in computational methods are accelerating the development of algorithm- and AI-based approaches in FBDD. However, it should be noted that certain methods do not provide synthetic pathways to obtain the proposed compounds. Consequently, these molecules might not be synthesized easily.

resultsWe present MOZAIC, a reaction-based fragment-growing framework that combines in silico reactions with Conformational Space Annealing for global molecular optimization. MOZAIC generates compounds through SMARTS-defined organic reactions, preserving reaction histories and providing putative synthetic routes. Across benchmark targets, MOZAIC produced chemically diverse molecules with balanced improvements in predicted binding affinity, drug-likeness, and synthetic accessibility. Compared with existing fragment-growing and generative approaches, MOZAIC achieved broad scaffold coverage while maintaining target-directed optimization. Its modular objective function also enabled alternative design goals, such as improving predicted solubility while maintaining binding affinity. AVAILABILITY AND IMPLEMENTATION: MOZAIC is available at https://github.com/kucm-lsbi/MOZAIC.

Indexed as

Computational BiologyDrug DiscoverySoftwareAlgorithmsComputer SimulationMolecular Conformation

Identifiers

PMID42568189
PMCPMC13493189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.